ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Alzheimer's Disease Blood Diagnostic Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-27Z17222
Home | Market Reports | Health| Aging & Geriatrics
Global Alzheimer s Disease Blood Diagnostic Market Research Report 2024
BUY CHAPTERS

Global Alzheimer's Disease Blood Diagnostic Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-27Z17222
Report
October 2025
Pages:144
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Quanterix
C2N Diagnostics
Sysmex
Quest Diagnostics
Roche Diagnostics
Eli Lilly and Company
Fujirebio
Amoneta Diagnostics
MagQu
Vazyme
Kingmed Diagnostics
Anqun Bioengineering

Alzheimer's Disease Blood Diagnostic Market

The global Alzheimer's Disease Blood Diagnostic market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Alzheimer's Disease (AD) blood diagnostic refers to a clinical test or series of tests that analyze specific biomarkers present in the blood to identify and diagnose Alzheimer's Disease. These diagnostics aim to detect the presence of pathological changes associated with AD, such as amyloid plaques, tau tangles, neurodegeneration, and other related abnormalities, using minimally invasive blood samples.
Alzheimer's Disease blood diagnostics represent a promising advancement in the field of neurodegenerative disease detection. By leveraging specific biomarkers and advanced analytical techniques, these tests offer a non-invasive, accessible, and potentially cost-effective means of diagnosing and monitoring Alzheimer's Disease, ultimately improving patient outcomes through earlier and more accurate diagnosis.
From a downstream perspective, Early Diagnosis accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Alzheimer's Disease Blood Diagnostic leading manufacturers including Quanterix, C2N Diagnostics, Sysmex, Quest Diagnostics, Roche Diagnostics, Eli Lilly and Company, Fujirebio, Amoneta Diagnostics, MagQu, Vazyme, etc., dominate supply; the top five capture approximately % of global revenue, with Quanterix leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Alzheimer's Disease Blood Diagnostic market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Alzheimer's Disease Blood Diagnostic Market Report

Report Metric Details
Report Name Alzheimer's Disease Blood Diagnostic Market
Segment by Type
Segment by Application
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Quanterix, C2N Diagnostics, Sysmex, Quest Diagnostics, Roche Diagnostics, Eli Lilly and Company, Fujirebio, Amoneta Diagnostics, MagQu, Vazyme, KingMed Diagnostics, Anqun Bioengineering
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Alzheimer's Disease Blood Diagnostic study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Alzheimer's Disease Blood Diagnostic Market report?

Ans: The main players in the Alzheimer's Disease Blood Diagnostic Market are Quanterix, C2N Diagnostics, Sysmex, Quest Diagnostics, Roche Diagnostics, Eli Lilly and Company, Fujirebio, Amoneta Diagnostics, MagQu, Vazyme, KingMed Diagnostics, Anqun Bioengineering

What are the Application segmentation covered in the Alzheimer's Disease Blood Diagnostic Market report?

Ans: The Applications covered in the Alzheimer's Disease Blood Diagnostic Market report are Early Diagnosis, Clinical Research

What are the Type segmentation covered in the Alzheimer's Disease Blood Diagnostic Market report?

Ans: The Types covered in the Alzheimer's Disease Blood Diagnostic Market report are Amyloid Beta (Aβ), Tau Proteins, Others

Recommended Reports

Alzheimer's Diagnostics

Blood Testing Devices

Blood Disease Diagnostics

1 Study Coverage
1.1 Introduction to Alzheimer's Disease Blood Diagnostic: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Alzheimer's Disease Blood Diagnostic Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Amyloid Beta (Aβ)
1.2.3 Tau Proteins
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Alzheimer's Disease Blood Diagnostic Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Early Diagnosis
1.3.3 Clinical Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Alzheimer's Disease Blood Diagnostic Revenue Estimates and Forecasts 2020-2031
2.2 Global Alzheimer's Disease Blood Diagnostic Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Alzheimer's Disease Blood Diagnostic Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Alzheimer's Disease Blood Diagnostic Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Amyloid Beta (Aβ) Market Size by Players
3.3.2 Tau Proteins Market Size by Players
3.3.3 Others Market Size by Players
3.4 Global Alzheimer's Disease Blood Diagnostic Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Alzheimer's Disease Blood Diagnostic Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Alzheimer's Disease Blood Diagnostic Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Alzheimer's Disease Blood Diagnostic Market Size by Type (2020-2031)
6.4 North America Alzheimer's Disease Blood Diagnostic Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Alzheimer's Disease Blood Diagnostic Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Alzheimer's Disease Blood Diagnostic Market Size by Type (2020-2031)
7.4 Europe Alzheimer's Disease Blood Diagnostic Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Alzheimer's Disease Blood Diagnostic Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Alzheimer's Disease Blood Diagnostic Market Size by Type (2020-2031)
8.4 Asia-Pacific Alzheimer's Disease Blood Diagnostic Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Alzheimer's Disease Blood Diagnostic Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Alzheimer's Disease Blood Diagnostic Market Size by Type (2020-2031)
9.4 Central and South America Alzheimer's Disease Blood Diagnostic Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Alzheimer's Disease Blood Diagnostic Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Alzheimer's Disease Blood Diagnostic Market Size by Type (2020-2031)
10.4 Middle East and Africa Alzheimer's Disease Blood Diagnostic Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Alzheimer's Disease Blood Diagnostic Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Quanterix
11.1.1 Quanterix Corporation Information
11.1.2 Quanterix Business Overview
11.1.3 Quanterix Alzheimer's Disease Blood Diagnostic Product Features and Attributes
11.1.4 Quanterix Alzheimer's Disease Blood Diagnostic Revenue and Gross Margin (2020-2025)
11.1.5 Quanterix Alzheimer's Disease Blood Diagnostic Revenue by Product in 2024
11.1.6 Quanterix Alzheimer's Disease Blood Diagnostic Revenue by Application in 2024
11.1.7 Quanterix Alzheimer's Disease Blood Diagnostic Revenue by Geographic Area in 2024
11.1.8 Quanterix Alzheimer's Disease Blood Diagnostic SWOT Analysis
11.1.9 Quanterix Recent Developments
11.2 C2N Diagnostics
11.2.1 C2N Diagnostics Corporation Information
11.2.2 C2N Diagnostics Business Overview
11.2.3 C2N Diagnostics Alzheimer's Disease Blood Diagnostic Product Features and Attributes
11.2.4 C2N Diagnostics Alzheimer's Disease Blood Diagnostic Revenue and Gross Margin (2020-2025)
11.2.5 C2N Diagnostics Alzheimer's Disease Blood Diagnostic Revenue by Product in 2024
11.2.6 C2N Diagnostics Alzheimer's Disease Blood Diagnostic Revenue by Application in 2024
11.2.7 C2N Diagnostics Alzheimer's Disease Blood Diagnostic Revenue by Geographic Area in 2024
11.2.8 C2N Diagnostics Alzheimer's Disease Blood Diagnostic SWOT Analysis
11.2.9 C2N Diagnostics Recent Developments
11.3 Sysmex
11.3.1 Sysmex Corporation Information
11.3.2 Sysmex Business Overview
11.3.3 Sysmex Alzheimer's Disease Blood Diagnostic Product Features and Attributes
11.3.4 Sysmex Alzheimer's Disease Blood Diagnostic Revenue and Gross Margin (2020-2025)
11.3.5 Sysmex Alzheimer's Disease Blood Diagnostic Revenue by Product in 2024
11.3.6 Sysmex Alzheimer's Disease Blood Diagnostic Revenue by Application in 2024
11.3.7 Sysmex Alzheimer's Disease Blood Diagnostic Revenue by Geographic Area in 2024
11.3.8 Sysmex Alzheimer's Disease Blood Diagnostic SWOT Analysis
11.3.9 Sysmex Recent Developments
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Corporation Information
11.4.2 Quest Diagnostics Business Overview
11.4.3 Quest Diagnostics Alzheimer's Disease Blood Diagnostic Product Features and Attributes
11.4.4 Quest Diagnostics Alzheimer's Disease Blood Diagnostic Revenue and Gross Margin (2020-2025)
11.4.5 Quest Diagnostics Alzheimer's Disease Blood Diagnostic Revenue by Product in 2024
11.4.6 Quest Diagnostics Alzheimer's Disease Blood Diagnostic Revenue by Application in 2024
11.4.7 Quest Diagnostics Alzheimer's Disease Blood Diagnostic Revenue by Geographic Area in 2024
11.4.8 Quest Diagnostics Alzheimer's Disease Blood Diagnostic SWOT Analysis
11.4.9 Quest Diagnostics Recent Developments
11.5 Roche Diagnostics
11.5.1 Roche Diagnostics Corporation Information
11.5.2 Roche Diagnostics Business Overview
11.5.3 Roche Diagnostics Alzheimer's Disease Blood Diagnostic Product Features and Attributes
11.5.4 Roche Diagnostics Alzheimer's Disease Blood Diagnostic Revenue and Gross Margin (2020-2025)
11.5.5 Roche Diagnostics Alzheimer's Disease Blood Diagnostic Revenue by Product in 2024
11.5.6 Roche Diagnostics Alzheimer's Disease Blood Diagnostic Revenue by Application in 2024
11.5.7 Roche Diagnostics Alzheimer's Disease Blood Diagnostic Revenue by Geographic Area in 2024
11.5.8 Roche Diagnostics Alzheimer's Disease Blood Diagnostic SWOT Analysis
11.5.9 Roche Diagnostics Recent Developments
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Corporation Information
11.6.2 Eli Lilly and Company Business Overview
11.6.3 Eli Lilly and Company Alzheimer's Disease Blood Diagnostic Product Features and Attributes
11.6.4 Eli Lilly and Company Alzheimer's Disease Blood Diagnostic Revenue and Gross Margin (2020-2025)
11.6.5 Eli Lilly and Company Recent Developments
11.7 Fujirebio
11.7.1 Fujirebio Corporation Information
11.7.2 Fujirebio Business Overview
11.7.3 Fujirebio Alzheimer's Disease Blood Diagnostic Product Features and Attributes
11.7.4 Fujirebio Alzheimer's Disease Blood Diagnostic Revenue and Gross Margin (2020-2025)
11.7.5 Fujirebio Recent Developments
11.8 Amoneta Diagnostics
11.8.1 Amoneta Diagnostics Corporation Information
11.8.2 Amoneta Diagnostics Business Overview
11.8.3 Amoneta Diagnostics Alzheimer's Disease Blood Diagnostic Product Features and Attributes
11.8.4 Amoneta Diagnostics Alzheimer's Disease Blood Diagnostic Revenue and Gross Margin (2020-2025)
11.8.5 Amoneta Diagnostics Recent Developments
11.9 MagQu
11.9.1 MagQu Corporation Information
11.9.2 MagQu Business Overview
11.9.3 MagQu Alzheimer's Disease Blood Diagnostic Product Features and Attributes
11.9.4 MagQu Alzheimer's Disease Blood Diagnostic Revenue and Gross Margin (2020-2025)
11.9.5 MagQu Recent Developments
11.10 Vazyme
11.10.1 Vazyme Corporation Information
11.10.2 Vazyme Business Overview
11.10.3 Vazyme Alzheimer's Disease Blood Diagnostic Product Features and Attributes
11.10.4 Vazyme Alzheimer's Disease Blood Diagnostic Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 KingMed Diagnostics
11.11.1 KingMed Diagnostics Corporation Information
11.11.2 KingMed Diagnostics Business Overview
11.11.3 KingMed Diagnostics Alzheimer's Disease Blood Diagnostic Product Features and Attributes
11.11.4 KingMed Diagnostics Alzheimer's Disease Blood Diagnostic Revenue and Gross Margin (2020-2025)
11.11.5 KingMed Diagnostics Recent Developments
11.12 Anqun Bioengineering
11.12.1 Anqun Bioengineering Corporation Information
11.12.2 Anqun Bioengineering Business Overview
11.12.3 Anqun Bioengineering Alzheimer's Disease Blood Diagnostic Product Features and Attributes
11.12.4 Anqun Bioengineering Alzheimer's Disease Blood Diagnostic Revenue and Gross Margin (2020-2025)
11.12.5 Anqun Bioengineering Recent Developments
12 Alzheimer's Disease Blood DiagnosticIndustry Chain Analysis
12.1 Alzheimer's Disease Blood Diagnostic Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Alzheimer's Disease Blood Diagnostic Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Alzheimer's Disease Blood Diagnostic Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Quanterix
C2N Diagnostics
Sysmex
Quest Diagnostics
Roche Diagnostics
Eli Lilly and Company
Fujirebio
Amoneta Diagnostics
MagQu
Vazyme
Kingmed Diagnostics
Anqun Bioengineering
List of Tables
 Table 1. Global Alzheimer's Disease Blood Diagnostic Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Alzheimer's Disease Blood Diagnostic Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Alzheimer's Disease Blood Diagnostic Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Alzheimer's Disease Blood Diagnostic Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Alzheimer's Disease Blood Diagnostic Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Alzheimer's Disease Blood Diagnostic Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Alzheimer's Disease Blood Diagnostic Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Alzheimer's Disease Blood Diagnostic by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Blood Diagnostic as of 2024)
 Table 11. Global Alzheimer's Disease Blood Diagnostic Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Alzheimer's Disease Blood Diagnostic Companies Headquarters
 Table 13. Global Alzheimer's Disease Blood Diagnostic Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Alzheimer's Disease Blood Diagnostic Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Alzheimer's Disease Blood Diagnostic Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Alzheimer's Disease Blood Diagnostic Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Alzheimer's Disease Blood Diagnostic Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Alzheimer's Disease Blood Diagnostic High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Alzheimer's Disease Blood Diagnostic Growth Accelerators and Market Barriers
 Table 25. North America Alzheimer's Disease Blood Diagnostic Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Alzheimer's Disease Blood Diagnostic Growth Accelerators and Market Barriers
 Table 27. Europe Alzheimer's Disease Blood Diagnostic Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Alzheimer's Disease Blood Diagnostic Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Alzheimer's Disease Blood Diagnostic Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Alzheimer's Disease Blood Diagnostic Investment Opportunities and Key Challenges
 Table 31. Central and South America Alzheimer's Disease Blood Diagnostic Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Alzheimer's Disease Blood Diagnostic Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Alzheimer's Disease Blood Diagnostic Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Quanterix Corporation Information
 Table 35. Quanterix Description and Major Businesses
 Table 36. Quanterix Product Features and Attributes
 Table 37. Quanterix Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Quanterix Revenue Proportion by Product in 2024
 Table 39. Quanterix Revenue Proportion by Application in 2024
 Table 40. Quanterix Revenue Proportion by Geographic Area in 2024
 Table 41. Quanterix Alzheimer's Disease Blood Diagnostic SWOT Analysis
 Table 42. Quanterix Recent Developments
 Table 43. C2N Diagnostics Corporation Information
 Table 44. C2N Diagnostics Description and Major Businesses
 Table 45. C2N Diagnostics Product Features and Attributes
 Table 46. C2N Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. C2N Diagnostics Revenue Proportion by Product in 2024
 Table 48. C2N Diagnostics Revenue Proportion by Application in 2024
 Table 49. C2N Diagnostics Revenue Proportion by Geographic Area in 2024
 Table 50. C2N Diagnostics Alzheimer's Disease Blood Diagnostic SWOT Analysis
 Table 51. C2N Diagnostics Recent Developments
 Table 52. Sysmex Corporation Information
 Table 53. Sysmex Description and Major Businesses
 Table 54. Sysmex Product Features and Attributes
 Table 55. Sysmex Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Sysmex Revenue Proportion by Product in 2024
 Table 57. Sysmex Revenue Proportion by Application in 2024
 Table 58. Sysmex Revenue Proportion by Geographic Area in 2024
 Table 59. Sysmex Alzheimer's Disease Blood Diagnostic SWOT Analysis
 Table 60. Sysmex Recent Developments
 Table 61. Quest Diagnostics Corporation Information
 Table 62. Quest Diagnostics Description and Major Businesses
 Table 63. Quest Diagnostics Product Features and Attributes
 Table 64. Quest Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Quest Diagnostics Revenue Proportion by Product in 2024
 Table 66. Quest Diagnostics Revenue Proportion by Application in 2024
 Table 67. Quest Diagnostics Revenue Proportion by Geographic Area in 2024
 Table 68. Quest Diagnostics Alzheimer's Disease Blood Diagnostic SWOT Analysis
 Table 69. Quest Diagnostics Recent Developments
 Table 70. Roche Diagnostics Corporation Information
 Table 71. Roche Diagnostics Description and Major Businesses
 Table 72. Roche Diagnostics Product Features and Attributes
 Table 73. Roche Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Roche Diagnostics Revenue Proportion by Product in 2024
 Table 75. Roche Diagnostics Revenue Proportion by Application in 2024
 Table 76. Roche Diagnostics Revenue Proportion by Geographic Area in 2024
 Table 77. Roche Diagnostics Alzheimer's Disease Blood Diagnostic SWOT Analysis
 Table 78. Roche Diagnostics Recent Developments
 Table 79. Eli Lilly and Company Corporation Information
 Table 80. Eli Lilly and Company Description and Major Businesses
 Table 81. Eli Lilly and Company Product Features and Attributes
 Table 82. Eli Lilly and Company Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Eli Lilly and Company Recent Developments
 Table 84. Fujirebio Corporation Information
 Table 85. Fujirebio Description and Major Businesses
 Table 86. Fujirebio Product Features and Attributes
 Table 87. Fujirebio Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Fujirebio Recent Developments
 Table 89. Amoneta Diagnostics Corporation Information
 Table 90. Amoneta Diagnostics Description and Major Businesses
 Table 91. Amoneta Diagnostics Product Features and Attributes
 Table 92. Amoneta Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Amoneta Diagnostics Recent Developments
 Table 94. MagQu Corporation Information
 Table 95. MagQu Description and Major Businesses
 Table 96. MagQu Product Features and Attributes
 Table 97. MagQu Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. MagQu Recent Developments
 Table 99. Vazyme Corporation Information
 Table 100. Vazyme Description and Major Businesses
 Table 101. Vazyme Product Features and Attributes
 Table 102. Vazyme Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Vazyme Recent Developments
 Table 104. KingMed Diagnostics Corporation Information
 Table 105. KingMed Diagnostics Description and Major Businesses
 Table 106. KingMed Diagnostics Product Features and Attributes
 Table 107. KingMed Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. KingMed Diagnostics Recent Developments
 Table 109. Anqun Bioengineering Corporation Information
 Table 110. Anqun Bioengineering Description and Major Businesses
 Table 111. Anqun Bioengineering Product Features and Attributes
 Table 112. Anqun Bioengineering Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Anqun Bioengineering Recent Developments
 Table 114. Raw Materials Key Suppliers
 Table 115. Distributors List
 Table 116. Market Trends and Market Evolution
 Table 117. Market Drivers and Opportunities
 Table 118. Market Challenges, Risks, and Restraints
 Table 119. Research Programs/Design for This Report
 Table 120. Key Data Information from Secondary Sources
 Table 121. Key Data Information from Primary Sources


List of Figures
 Figure 1. Alzheimer's Disease Blood Diagnostic Product Picture
 Figure 2. Global Alzheimer's Disease Blood Diagnostic Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Amyloid Beta (Aβ) Product Picture
 Figure 4. Tau Proteins Product Picture
 Figure 5. Others Product Picture
 Figure 6. Global Alzheimer's Disease Blood Diagnostic Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Early Diagnosis
 Figure 8. Clinical Research
 Figure 9. Alzheimer's Disease Blood Diagnostic Report Years Considered
 Figure 10. Global Alzheimer's Disease Blood Diagnostic Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Alzheimer's Disease Blood Diagnostic Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Alzheimer's Disease Blood Diagnostic Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Alzheimer's Disease Blood Diagnostic Revenue Market Share by Region (2020-2031)
 Figure 14. Global Alzheimer's Disease Blood Diagnostic Revenue Market Share Ranking (2024)
 Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 16. Amyloid Beta (Aβ) Revenue Market Share by Player in 2024
 Figure 17. Tau Proteins Revenue Market Share by Player in 2024
 Figure 18. Others Revenue Market Share by Player in 2024
 Figure 19. Global Alzheimer's Disease Blood Diagnostic Revenue Market Share by Type (2020-2031)
 Figure 20. Global Alzheimer's Disease Blood Diagnostic Revenue Market Share by Application (2020-2031)
 Figure 21. North America Alzheimer's Disease Blood Diagnostic Revenue YoY (2020-2031) & (US$ Million)
 Figure 22. North America Top 5 Players Alzheimer's Disease Blood Diagnostic Revenue (US$ Million) in 2024
 Figure 23. North America Alzheimer's Disease Blood Diagnostic Revenue (US$ Million) by Type (2020 - 2031)
 Figure 24. North America Alzheimer's Disease Blood Diagnostic Revenue (US$ Million) by Application (2020-2031)
 Figure 25. US Alzheimer's Disease Blood Diagnostic Revenue (2020-2031) & (US$ Million)
 Figure 26. Canada Alzheimer's Disease Blood Diagnostic Revenue (2020-2031) & (US$ Million)
 Figure 27. Mexico Alzheimer's Disease Blood Diagnostic Revenue (2020-2031) & (US$ Million)
 Figure 28. Europe Alzheimer's Disease Blood Diagnostic Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. Europe Top 5 Players Alzheimer's Disease Blood Diagnostic Revenue (US$ Million) in 2024
 Figure 30. Europe Alzheimer's Disease Blood Diagnostic Revenue (US$ Million) by Type (2020-2031)
 Figure 31. Europe Alzheimer's Disease Blood Diagnostic Revenue (US$ Million) by Application (2020-2031)
 Figure 32. Germany Alzheimer's Disease Blood Diagnostic Revenue (2020-2031) & (US$ Million)
 Figure 33. France Alzheimer's Disease Blood Diagnostic Revenue (2020-2031) & (US$ Million)
 Figure 34. U.K. Alzheimer's Disease Blood Diagnostic Revenue (2020-2031) & (US$ Million)
 Figure 35. Italy Alzheimer's Disease Blood Diagnostic Revenue (2020-2031) & (US$ Million)
 Figure 36. Russia Alzheimer's Disease Blood Diagnostic Revenue (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Alzheimer's Disease Blood Diagnostic Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Top 8 Players Alzheimer's Disease Blood Diagnostic Revenue (US$ Million) in 2024
 Figure 39. Asia-Pacific Alzheimer's Disease Blood Diagnostic Revenue (US$ Million) by Type (2020-2031)
 Figure 40. Asia-Pacific Alzheimer's Disease Blood Diagnostic Revenue (US$ Million) by Application (2020-2031)
 Figure 41. Indonesia Alzheimer's Disease Blood Diagnostic Revenue (2020-2031) & (US$ Million)
 Figure 42. Japan Alzheimer's Disease Blood Diagnostic Revenue (2020-2031) & (US$ Million)
 Figure 43. South Korea Alzheimer's Disease Blood Diagnostic Revenue (2020-2031) & (US$ Million)
 Figure 44. Australia Alzheimer's Disease Blood Diagnostic Revenue (2020-2031) & (US$ Million)
 Figure 45. India Alzheimer's Disease Blood Diagnostic Revenue (2020-2031) & (US$ Million)
 Figure 46. Indonesia Alzheimer's Disease Blood Diagnostic Revenue (2020-2031) & (US$ Million)
 Figure 47. Vietnam Alzheimer's Disease Blood Diagnostic Revenue (2020-2031) & (US$ Million)
 Figure 48. Malaysia Alzheimer's Disease Blood Diagnostic Revenue (2020-2031) & (US$ Million)
 Figure 49. Philippines Alzheimer's Disease Blood Diagnostic Revenue (2020-2031) & (US$ Million)
 Figure 50. Singapore Alzheimer's Disease Blood Diagnostic Revenue (2020-2031) & (US$ Million)
 Figure 51. Central and South America Alzheimer's Disease Blood Diagnostic Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Central and South America Top 5 Players Alzheimer's Disease Blood Diagnostic Revenue (US$ Million) in 2024
 Figure 53. Central and South America Alzheimer's Disease Blood Diagnostic Revenue (US$ Million) by Type (2020-2031)
 Figure 54. Central and South America Alzheimer's Disease Blood Diagnostic Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Brazil Alzheimer's Disease Blood Diagnostic Revenue (2020-2025) & (US$ Million)
 Figure 56. Argentina Alzheimer's Disease Blood Diagnostic Revenue (2020-2025) & (US$ Million)
 Figure 57. Middle East and Africa Alzheimer's Disease Blood Diagnostic Revenue YoY (2020-2031) & (US$ Million)
 Figure 58. Middle East and Africa Top 5 Players Alzheimer's Disease Blood Diagnostic Revenue (US$ Million) in 2024
 Figure 59. South America Alzheimer's Disease Blood Diagnostic Revenue (US$ Million) by Type (2020-2031)
 Figure 60. Middle East and Africa Alzheimer's Disease Blood Diagnostic Revenue (US$ Million) by Application (2020-2031)
 Figure 61. GCC Countries Alzheimer's Disease Blood Diagnostic Revenue (2020-2025) & (US$ Million)
 Figure 62. Israel Alzheimer's Disease Blood Diagnostic Revenue (2020-2025) & (US$ Million)
 Figure 63. Egypt Alzheimer's Disease Blood Diagnostic Revenue (2020-2025) & (US$ Million)
 Figure 64. South Africa Alzheimer's Disease Blood Diagnostic Revenue (2020-2025) & (US$ Million)
 Figure 65. Alzheimer's Disease Blood Diagnostic Industry Chain Mapping
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Blood Tests for Alzheimer s Diagnosis Market Research Report 2024
Global Alzheimer s Blood Tests Market Research Report 2024
Global Alzheimer s Disease AD Blood based Detection Kits Market Research Report 2024
Global Alzheimer s Disease Blood Test Kit Market Research Report 2024
Global Blood based Detection Kit for Early Diagnosis of Alzheimer s Disease Market Research Report 2024
Global Alzheimer s Disease Diagnosis Market Research Report 2024
Alzheimer s Disease Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Alzheimer s Disease Therapeutics and Diagnostics Market Insights Forecast to 2030
Alzheimer Disease Genetic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Alzheimer Disease DNA Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Research Report 2024
Global Apolipoprotein Testing Market Research Report 2025
Global Blood Testing Devices Market Research Report 2024
Global Dementia Diagnosis App Market Research Report 2024
Global Dementia Diagnosis Solutions Market Research Report 2024
Global Monoclonal Antibodies for Alzheimer Disease Market Research Report 2024
Global Alzheimer s Disease Drug Market Insights Forecast to 2030
Global Alzheimer s Disease Treatments Market Research Report 2024
Dementia and Alzheimer s Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Blood Cancer Detection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions